Search

Author/Creator Lovett, Jacqueline

1. (R)‐Ketamine exerts antidepressant actions partly via conversion to (2R, 6R)‐hydroxynorketamine, while causing adverse effects at sub‐anaesthetic doses. (13th May 2019)

Authors:
Zanos, Panos; Highland, Jaclyn N.; Liu, Xin; Troppoli, Timothy A.; Georgiou, Polymnia; Lovett, Jacqueline; Morris, Patrick J.; Stewart, Brent W.; Thomas, Craig J.; Thompson, Scott M.; Moaddel, Ruin; Gould, Todd D.
Journal:
British journal of pharmacology
Issue:
Volume 176:Number 14(2019)
Page Start:
2573
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R, 6R)-hydroxynorketamine. (January 2019)

Authors:
Highland, Jaclyn N; Morris, Patrick J; Zanos, Panos; Lovett, Jacqueline; Ghosh, Soumita; Wang, Amy Q; Zarate, Carlos A; Thomas, Craig J; Moaddel, Ruin; Gould, Todd D
Journal:
Journal of psychopharmacology
Issue:
Volume 33:Number 1(2019)
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin. Issue 1 (14th December 2022)

Authors:
Vreones, Michael; Mustapic, Maja; Moaddel, Ruin; Pucha, Krishna A.; Lovett, Jacqueline; Seals, Douglas R.; Kapogiannis, Dimitrios; Martens, Christopher R.
Journal:
Aging cell
Issue:
Volume 22:Issue 1(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗